Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-02-09 Sale(A) | 2022-05-27 4:20 pm | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 159,177 | $16 | $2,546,832 | 1,439,525 (Direct) | View |
2022-05-25 Purchase | 2022-05-27 4:18 pm | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 11,313 | $1.2466 | $14,103 | 1,891,947 (Direct) | View |
2022-05-20 Purchase | 2022-05-25 5:58 pm | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 82,200 | $1.2339 | $101,428 | 1,721,457 (Direct) | View |
2021-12-27 Purchase | 2021-12-29 4:08 pm | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 277,244 | $2.6344 | $730,373 | 1,639,257 (Direct) | View |
2021-12-20 Purchase | 2021-12-22 4:06 pm | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 3,527 | $2.5449 | $8,976 | 1,362,013 (Direct) | View |
2021-12-16 Purchase | 2021-12-20 6:44 pm | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 41,625 | $2.5454 | $105,951 | 1,358,486 (Direct) | View |
2021-12-15 Purchase | 2021-12-17 5:13 pm | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 77,604 | $2.4091 | $186,956 | 1,316,861 (Direct) | View |
2021-09-17 Sale | 2021-09-21 5:14 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner | 400,000 | $9.4 | $3,760,000 | 2,856,309 (Indirect Direct) | View |
2021-02-09 Sale | 2021-02-11 7:25 pm | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 159,177 | $16 | $2,546,832 | 1,280,348 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-12-28 Option Award | 2023-12-29 5:05 pm | N/A 2033-12-28 | Elicio Therapeutics Inc. | ELTX | Venkatesan Jay Director | 4,100 | $0 | 4,100 (Direct) | View |
2022-07-15 Exercise | 2022-07-19 4:38 pm | N/A 2025-12-15 | ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner | 20,063 | $0.45 | 2,946,372 (Direct) | View |
2021-02-09 Exercise(A) | 2022-05-27 4:20 pm | N/A 2028-07-05 | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 396,329 | $0 | 1,439,525 (Direct) | View |
2021-02-09 Conversion(A) | 2022-05-27 4:20 pm | N/A N/A | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 262 | $11.57 | 1,439,525 (Direct) | View |
2021-02-09 Exercise(A) | 2022-05-27 4:20 pm | N/A N/A | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 396,329 | $6.43 | 1,439,525 (Direct) | View |
2022-03-03 Option Award | 2022-03-04 4:22 pm | N/A 2032-03-02 | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 760,000 | $0 | 1,360,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-04 5:37 pm | N/A 2032-01-02 | ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
2021-06-24 Tax Withholding | 2021-12-17 5:13 pm | N/A N/A | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 41,091 | $13.78 | 1,316,861 (Direct) | View |
2021-03-30 Exercise | 2021-04-23 6:14 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner | 7,650 | $4.09 | 3,256,309 (Direct) | View |
2021-03-30 Exercise | 2021-04-23 6:14 pm | N/A 2029-01-01 | ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner | 15,300 | $0 | 3,256,309 (Direct) | View |
2021-03-31 Exercise | 2021-04-23 6:14 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner | 7,650 | $3.6233 | 3,256,309 (Direct) | View |
2021-02-09 Exercise | 2021-02-11 7:25 pm | N/A 2028-07-05 | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 237,152 | $0 | 1,280,348 (Direct) | View |
2021-02-09 Conversion | 2021-02-11 7:25 pm | N/A N/A | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 262 | $11.57 | 1,280,348 (Direct) | View |
2021-02-09 Conversion | 2021-02-11 7:25 pm | N/A N/A | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 170,037 | $0 | 1,280,348 (Direct) | View |
2021-02-09 Tax Withholding | 2021-02-11 7:25 pm | N/A N/A | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 31,966 | $16 | 1,280,348 (Direct) | View |
2021-02-09 Exercise | 2021-02-11 7:25 pm | N/A N/A | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 237,152 | $6.43 | 1,280,348 (Direct) | View |
2021-02-04 Option Award | 2021-02-08 12:57 pm | N/A 2031-02-03 | Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks | 178,920 | $0 | 178,920 (Direct) | View |
Ownership | 2021-02-04 5:31 pm | N/A N/A | Angion Biomedica Corp. | ANG | Venkatesan Jay See Remarks | 0 | $0 | 2,638,158 (Direct) | View |
2021-01-04 Option Award | 2021-01-05 7:03 pm | N/A 2031-01-03 | ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner | 7,650 | $0 | 7,650 (Direct) | View |
2020-12-22 Other | 2020-12-22 5:30 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner | 1,174,825 | $0 | 4,415,834 (Indirect) | View |
2020-07-06 Exercise | 2020-07-08 4:46 pm | N/A 2024-02-17 | EXICURE INC. | XCUR | Venkatesan Jay Director | 22,240 | $0 | 672,288 (Direct) | View |
2020-07-06 Exercise | 2020-07-08 4:46 pm | N/A N/A | EXICURE INC. | XCUR | Venkatesan Jay Director | 9,310 | $0.65 | 672,288 (Direct) | View |
2020-07-06 Exercise | 2020-07-08 4:46 pm | N/A N/A | EXICURE INC. | XCUR | Venkatesan Jay Director | 12,930 | $1.03 | 672,288 (Direct) | View |
2020-06-04 Option Award | 2020-06-08 7:22 pm | N/A 2030-06-03 | EXICURE INC. | XCUR | Venkatesan Jay Director | 21,693 | $0 | 21,693 (Direct) | View |
2020-01-02 Option Award | 2020-01-06 8:02 pm | N/A 2030-01-01 | ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner | 7,650 | $0 | 7,650 (Direct) | View |